A Message from NCTracks on Behalf of NC Medicaid Lantus Update on NC Medicaid Preferred Drug List

Due to reports of access challenges with the insulin glargine vial / SoloStar® (authorized biologic for Lantus), Lantus® SoloStar® / Vial will move to preferred on the NC Medicaid Preferred Drug List (PDL), effective 3/24/2023.

Both insulin glargine vial / SoloStar® and Lantus® SoloStar® / Vial will have preferred status on the PDL. Insulin glargine continues to be the most cost-effective option for NC Medicaid.

Additionally, temporary PA overrides will be provided through NCTracks for Lantus® through 3/24/2023, at which time the PDL will be updated to include Lantus® as a preferred product. This applies to Medicaid Direct. For Managed Care Medicaid Plans, please refer to the individual plan.

Both Lantus® and insulin glargine will remain preferred until DHB Pharmacy receives sufficient notice that the access issues have been adequately resolved for pharmacies.